S
STEM CELLS LIMITED
At StemCore, we don't just believe in the power of regenerative medicine, we believe in the power of people driving this research at the very heart of it. The people that work tirelessly, from early morning to late in the night oblivious to weekends or Christmas holidays. Why do we do it? Because our passion is fueled by scientific curiosity, because we are passionate to make a difference, to save lives, to forever erase degenerative diseases. At StemCore, we believe in giving stem-cell academics the best support they can get so that you can focus on what you do best. Because Your Research Matters.
Country/Area ：Australia
Company Email ：info@stemcore.com.au
Industry ：--
Company website ：*****
Established ：-
Number of employees ：11-50
Web Summary
Q1: What is the company name and its address?
A1: The company name is Stem Cells Limited, but the provided text does not explicitly mention the exact address. However, based on the information available on their official website, it can be inferred that they are located in Australia.
Q2: What products and services does StemCore offer?
A2: StemCore offers a wide range of products and services related to pluripotent stem cells (PSCs), including gene-edited or non-edited human embryonic stem cells (hESCs) and induced PSCs (iPSCs), single-cell isolation, clonal cell-line development, genomic and functional characterisations, process development and optimisation, somatic cell reprogramming to iPSCs, gene-edited iPSCs and custom reporter cell lines, lineage-specific cell manufacturing, training, consultation, and grant collaboration.
Q3: What industry does StemCore operate in?
A3: StemCore operates in the biotechnology and regenerative medicine industries, specifically in the field of stem cell research and development.
Q4: Who is on the board of directors of StemCore?
A4: The provided text mentions that Prof. Susie Nilsson has joined the StemCore board to support its growth and pursuit of excellence. However, it does not provide a comprehensive list of the entire board of directors.
Q5: What is the composition of the StemCore scientific team?
A5: The StemCore scientific team consists of manager, research specialists, molecular biologists, and quality system experts, all integrated to provide high-quality stem cell-related services. The team includes Andrew Prose, PhD (Facility Manager), Desi Veleva, PhD (Research Specialist), and Merve Ay, MSc (Research Specialist).
Q6: What is the experience of Andrew Prose, PhD, in pluripotent stem cell biology?
A6: Andrew Prose has over 20 years' experience in pluripotent stem cell biology, bioprocess, project management, and commercialization. He received his PhD in 2008 from the University of New South Wales looking at improvements to pluripotent cell expansion through low oxygen culture and proteomic assessment of feeder layer secretomes.
Q7: What is Desi Veleva's area of expertise?
A7: Desi Veleva has extensive knowledge and expertise in reprogramming and differentiation, as well as neurogenesis and stem cell biology. She is responsible for project planning, process development, research, innovation, and laboratory management at StemCore.
Q8: What is Merve Ay's background and experience?
A8: Merve Ay graduated with a Bachelor of Science in Molecular Biology and Genetics from the Istanbul Kultur University (Turkey) in 2016. She joined StemCore under a mentorship program in 2018, where she gained advanced cell culture skills, reprogramming experience, and cell analysis techniques.
A1: The company name is Stem Cells Limited, but the provided text does not explicitly mention the exact address. However, based on the information available on their official website, it can be inferred that they are located in Australia.
Q2: What products and services does StemCore offer?
A2: StemCore offers a wide range of products and services related to pluripotent stem cells (PSCs), including gene-edited or non-edited human embryonic stem cells (hESCs) and induced PSCs (iPSCs), single-cell isolation, clonal cell-line development, genomic and functional characterisations, process development and optimisation, somatic cell reprogramming to iPSCs, gene-edited iPSCs and custom reporter cell lines, lineage-specific cell manufacturing, training, consultation, and grant collaboration.
Q3: What industry does StemCore operate in?
A3: StemCore operates in the biotechnology and regenerative medicine industries, specifically in the field of stem cell research and development.
Q4: Who is on the board of directors of StemCore?
A4: The provided text mentions that Prof. Susie Nilsson has joined the StemCore board to support its growth and pursuit of excellence. However, it does not provide a comprehensive list of the entire board of directors.
Q5: What is the composition of the StemCore scientific team?
A5: The StemCore scientific team consists of manager, research specialists, molecular biologists, and quality system experts, all integrated to provide high-quality stem cell-related services. The team includes Andrew Prose, PhD (Facility Manager), Desi Veleva, PhD (Research Specialist), and Merve Ay, MSc (Research Specialist).
Q6: What is the experience of Andrew Prose, PhD, in pluripotent stem cell biology?
A6: Andrew Prose has over 20 years' experience in pluripotent stem cell biology, bioprocess, project management, and commercialization. He received his PhD in 2008 from the University of New South Wales looking at improvements to pluripotent cell expansion through low oxygen culture and proteomic assessment of feeder layer secretomes.
Q7: What is Desi Veleva's area of expertise?
A7: Desi Veleva has extensive knowledge and expertise in reprogramming and differentiation, as well as neurogenesis and stem cell biology. She is responsible for project planning, process development, research, innovation, and laboratory management at StemCore.
Q8: What is Merve Ay's background and experience?
A8: Merve Ay graduated with a Bachelor of Science in Molecular Biology and Genetics from the Istanbul Kultur University (Turkey) in 2016. She joined StemCore under a mentorship program in 2018, where she gained advanced cell culture skills, reprogramming experience, and cell analysis techniques.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
